Abstract:Fifty women with singleton pregnancies between 26+0/7 and 33+6/7 weeks of gestation and arrested preterm labour (PTL) after acute tocolysis were randomised by a computer generated randomisation table into an intervention group (n = 25) who received maintenance tocolysis with tablet nifedipine for 12 days or up to 34 weeks of gestation, whichever was later and a control group (n = 25). The primary outcome was achievement of term gestation and the secondary outcomes were the number of days gained till delivery and neonatal mortality and morbidity. The mean gestation at admission, cervical dilatation and effacement were similar in the two groups (30 + weeks, 2.5 cm, 60%). In the intervention group, 7/25 (28%) and in the control group, 2/25 (8%) delivered at term (p = .066) and pregnancy prolongation of 20 days (IQR 2.5-51) and 14 days (IQR 1-27.5) were achieved, respectively (p = .269). Maintenance tocolysis was given for a median of 14 days (range 3-25.5). Kaplan-Meier analysis showed no statistically significant difference in prolongation of pregnancy between the control and the intervention groups (p = .077). The median number of days of neonatal hospital stay were reduced with maintenance tocolysis, but the difference was not significant (4.0 vs 5.5; p = .608). The mean birth weight was significantly higher in the intervention group (2266 vs 1880 g, p = .044). Among women at a high risk for preterm birth (PTB) due to established PTL as evidenced by a mean cervical dilatation of 2.5 cm and a PTB rate of 92% in the control group, maintenance tocolysis did not prolong the pregnancy or reduce the neonatal hospital stay significantly. Impact statement What is already known on this subject: In women with preterm labour (PTL) the role of maintenance tocolysis following acute tocolysis to reduce recurrent PTL is uncertain. Of the six studies using nifedipine, one reported pregnancy prolongation (26.65 vs 16.14 days, p = .007), but similar perinatal outcome (Sayin et al. 2004 ). Others did not find pregnancy prolongation (Carr et al. 1999 ; Lyell et al. 2008 ; Uma et al. 2012 ; Roos et al. 2013 ; Parry et al. 2014 ). The PTB rate in the control groups ranged from 38 to 67%. A Cochrane review reported pregnancy prolongation by 5.35 days but similar neonatal outcome (RR 0.75) (Naik et al. 2013 ). A meta-analysis including five studies using progesterone and five using nifedipine concluded that progesterone, but not nifedipine, prolonged pregnancy (Ding et al. 2016 ). Thus, data on maintenance tocolysis is limited and inconclusive. What the results of this study add: In the present randomised study in 50 women with arrested PTL, 25 received maintenance tocolysis. The mean gestation at admission, cervical dilatation and effacement were similar in the two groups (30+ weeks, 2.5cm, 60%). In the intervention group, 7/25 (28%) and controls, 2/25 (8%) delivered at term (p = .066) and pregnancy prolongation of 20 days (IQR 2.5-51) and 14 days (IQR 1-27.5) were achieved, respectively (p = .269). Kaplan-Meier analysis showed no statistically significant difference in prolongation of pregnancy between the control and the intervention groups (p = .077). The median number of days of neonatal hospital stay were reduced with maintenance tocolysis but the difference was not significant (4.0 vs 5.5; p = .608). What are the implications of these findings for clinical practice and/or future research: The mean birth weight was higher in the intervention group (2266 vs 1880g, p = .044). Future studies should take cervical dilatation and the PTB rate in the control group into consideration while assessing the impact of maintenance tocolysis.

Method to evaluate intravenous maintenance tocolysis for preterm labor

Clinical Analysis of Tocolysis with Ritodrine Hydrochloride or Atosibanin Treatment of Threatened Preterm Labour

Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome

Tocolysis for Acute Preterm Labor: Where Have We Been, Where Are We Now, and Where are We Going?

The use of vaginal progesterone as a maintenance therapy in women with arrested preterm labor: a double-blind placebo–randomized controlled trial

The effect of tocolytic use in the management of symptomatic placenta previa

[Analysis on the Outcome of Vaginal Trial Delivery in Singleton Full-Term Pregnancy with Low-Lying Placenta].

Effectiveness of the contemporary treatment of preterm labor: a comparison with a historical cohort

Associations Between Periodontal Status and Delivery Outcomes in Pregnant Women with a Diagnosis of Threatened Premature Labor

[Analysis of Periodontal Status in Pregnant Women with a Diagnosis of Threatened Premature Labor].

Vaginal Progesterone for Pregnancy Prolongation After Arrested Preterm Labor: A Randomized Clinical Trial

Associated Factors and Pregnancy Outcomes of Trial of Labor after Cesarean: a Prospective Cohort Study

Study on the Intervention of Early Preterm Labor

Four kinds of tocolytic therapy for preterm delivery: Systematic review and network meta-analysis

Use of Tocolytic Agents in Preterm Labor: A Cross‐Sectional Analysis from a Chinese Real‐World Study from 2016 to 2021

Influence of Epidural Labor Analgesia on Maternal and Neonatal Outcomes of Trial of Labor after Cesarean Section

Neonatal and maternal outcomes at early vs. full term following induction of labor; A secondary analysis of the OBLIGE randomized trial

Differences between evidence-based recommendations and actual clinical practice regarding tocolysis: a prospective multicenter registry study

Induction of labor and risk of postpartum hemorrhage in women with vaginal delivery: A propensity score analysis

Tocolytic Treatment for the Prevention of Preterm Birth from a Taiwanese Perspective: A Survey of Taiwanese Obstetric Specialists

Study on the timing and approach of pregnant termination for prolonged pregnancy